30
Participants
Start Date
December 1, 2024
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
FAPI PET/CT
This study applies the radiopharmaceutical 18Fluor-FAPI-74 (FAPI) for molecular imaging of FAP expression in vivo with FAPI PET/CT, to assess the presence and distribution of activated Cancer associated fibroblasts as a marker of Tumor Micro-Environment and indirectly as a marker for malignancies.
The Netherlands Cancer Institute
OTHER